Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04132817
Title A Study of Multiple Immune and Disease Treatment Combinations in Participants With ER+HER2- Breast Cancer That Has Spread
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Local Institution Los Angeles California 90033 United States Details
Local Institution - 0003 Sacramento California 95817 United States Details
Local Institution - 0009 Aurora Colorado 80045 United States Details
Local Institution - 0002 Saint Louis Missouri 63110 United States Details
Local Institution - 0008 New York New York 10016 United States Details
Local Institution Pittsburgh Pennsylvania 15213 United States Details
Local Institution Dallas Texas 75390 United States Details
South Texas Accelerated Research Therapeutics San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field